Literature DB >> 33221774

Influence of gender, ASA physical status, the location of a tumor and stage of the disease on the survival rate in patients with rectal cancer after surgery.

N Arslani1.   

Abstract

BACKGROUND: There are limited data describing different factors that influence survival rate of patients with rectal cancer. AIMS: Our aim was to determine the influence of patient gender, American Society of Anesthesiologists (ASA) physical status, the location of the tumor and stage of the disease on the patient survival rates after excision of rectal cancer. SETTINGS AND
DESIGN: We included 385 patients who were operated between 2004 and 2014 in the University Clinical Center Maribor. The patients were treated due to rectal adenocarcinoma. We assessed survival rates according to gender, ASA physical status, the location of the tumor and stage of the disease with different statistical methods. SUBJECTS AND METHODS: To find the extent of correlation between factors and survival rate, we used means and medians, Log Rank test, Breslow test and Tarone-Ware test.
RESULTS: According to patient gender, survival rate did not differ significantly (P > 0.05), however ASA physical status (P < 0.05), location of the tumor (P < 0.05) and stage of the disease (P < 0.05) significantly affected the survival rates.
CONCLUSIONS: Our study showed that gender does not have a significant impact on survival rate as oposed to ASA physical status, the location of the tumor and stage of the disease.

Entities:  

Keywords:  ASA; gender; location; rectal cancer; survival rate; tumor

Mesh:

Year:  2020        PMID: 33221774     DOI: 10.4103/njcp.njcp_437_19

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  1 in total

1.  The impact of the surgical Apgar score on oncological outcomes in patients with colorectal cancer: a propensity score-matched study.

Authors:  Atsushi Sugimoto; Tatsunari Fukuoka; Hisashi Nagahara; Masatsune Shibutani; Yasuhito Iseki; Maho Sasaki; Yuki Okazaki; Kiyoshi Maeda; Masaichi Ohira
Journal:  World J Surg Oncol       Date:  2022-03-10       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.